1. Home
  2. IX vs KVUE Comparison

IX vs KVUE Comparison

Compare IX & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orix Corp Ads

IX

Orix Corp Ads

HOLD

Current Price

$30.01

Market Cap

32.1B

Sector

Finance

ML Signal

HOLD

Logo Kenvue Inc.

KVUE

Kenvue Inc.

HOLD

Current Price

$17.24

Market Cap

34.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IX
KVUE
Founded
1950
2022
Country
Japan
United States
Employees
51921
N/A
Industry
Diversified Financial Services
Specialty Chemicals
Sector
Finance
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
32.1B
34.9B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
IX
KVUE
Price
$30.01
$17.24
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$19.73
AVG Volume (30 Days)
424.7K
22.0M
Earning Date
05-11-2026
05-07-2026
Dividend Yield
2.60%
4.81%
EPS Growth
N/A
40.74
EPS
N/A
0.76
Revenue
N/A
$15,124,000,000.00
Revenue This Year
$7.82
$4.82
Revenue Next Year
$5.97
$2.61
P/E Ratio
$12.93
$22.70
Revenue Growth
N/A
N/A
52 Week Low
$17.75
$14.02
52 Week High
$37.04
$25.17

Technical Indicators

Market Signals
Indicator
IX
KVUE
Relative Strength Index (RSI) 42.79 36.30
Support Level $29.41 $17.20
Resistance Level $30.82 $17.57
Average True Range (ATR) 0.55 0.30
MACD -0.04 -0.04
Stochastic Oscillator 52.43 30.84

Price Performance

Historical Comparison
IX
KVUE

About IX Orix Corp Ads

ORIX Corp is a diversified financial services company with operations in Corporate Financial Services, Maintenance Leasing, Real Estate, PE Investment and Concession, Environment and Energy, Insurance, Banking and Credit, Aircraft and Ships, ORIX USA, ORIX Europe, Asia, and Australia and engages in various other fee businesses by providing products and services aligned with customer needs to its core customer base of domestic small and medium-sized enterprises. Orix's numerous divisions finance leases of large-ticket items like ships, airplanes, and technology equipment. The company generates the majority of its revenue from Corporate Financial Services and Maintenance Leasing operations and Real Estate operations.

About KVUE Kenvue Inc.

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Share on Social Networks: